These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

972 related articles for article (PubMed ID: 22110105)

  • 1. Urinary sodium and potassium excretion and risk of cardiovascular events.
    O'Donnell MJ; Yusuf S; Mente A; Gao P; Mann JF; Teo K; McQueen M; Sleight P; Sharma AM; Dans A; Probstfield J; Schmieder RE
    JAMA; 2011 Nov; 306(20):2229-38. PubMed ID: 22110105
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Urinary sodium and potassium excretion, mortality, and cardiovascular events.
    O'Donnell M; Mente A; Rangarajan S; McQueen MJ; Wang X; Liu L; Yan H; Lee SF; Mony P; Devanath A; Rosengren A; Lopez-Jaramillo P; Diaz R; Avezum A; Lanas F; Yusoff K; Iqbal R; Ilow R; Mohammadifard N; Gulec S; Yusufali AH; Kruger L; Yusuf R; Chifamba J; Kabali C; Dagenais G; Lear SA; Teo K; Yusuf S;
    N Engl J Med; 2014 Aug; 371(7):612-23. PubMed ID: 25119607
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Joint association of urinary sodium and potassium excretion with cardiovascular events and mortality: prospective cohort study.
    O'Donnell M; Mente A; Rangarajan S; McQueen MJ; O'Leary N; Yin L; Liu X; Swaminathan S; Khatib R; Rosengren A; Ferguson J; Smyth A; Lopez-Jaramillo P; Diaz R; Avezum A; Lanas F; Ismail N; Yusoff K; Dans A; Iqbal R; Szuba A; Mohammadifard N; Oguz A; Yusufali AH; Alhabib KF; Kruger IM; Yusuf R; Chifamba J; Yeates K; Dagenais G; Wielgosz A; Lear SA; Teo K; Yusuf S;
    BMJ; 2019 Mar; 364():l772. PubMed ID: 30867146
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cognitive impairment and risk of cardiovascular events and mortality.
    O'Donnell M; Teo K; Gao P; Anderson C; Sleight P; Dans A; Marzona I; Bosch J; Probstfield J; Yusuf S
    Eur Heart J; 2012 Jul; 33(14):1777-86. PubMed ID: 22551598
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Sodium Excretion and the Risk of Cardiovascular Disease in Patients With Chronic Kidney Disease.
    Mills KT; Chen J; Yang W; Appel LJ; Kusek JW; Alper A; Delafontaine P; Keane MG; Mohler E; Ojo A; Rahman M; Ricardo AC; Soliman EZ; Steigerwalt S; Townsend R; He J;
    JAMA; 2016 May 24-31; 315(20):2200-10. PubMed ID: 27218629
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The relation between urinary sodium and potassium excretion and risk of cardiovascular events and mortality in patients with cardiovascular disease.
    Groenland EH; Vendeville JP; Bots ML; de Borst GJ; Nathoe HM; Ruigrok YM; Blankestijn PJ; Visseren FLJ; Spiering W;
    PLoS One; 2022; 17(3):e0265429. PubMed ID: 35298524
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Sodium Intake and Incident Atrial Fibrillation in Individuals With Vascular Disease.
    Johnson LS; Mente A; Joseph P; Conen D; Benz AP; McIntyre WF; Drake I; Engström G; Connolly SJ; Yusuf S; Healey JS
    JAMA Netw Open; 2024 Jul; 7(7):e2421589. PubMed ID: 38990569
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Urinary Potassium Excretion and Renal and Cardiovascular Complications in Patients with Type 2 Diabetes and Normal Renal Function.
    Araki S; Haneda M; Koya D; Kondo K; Tanaka S; Arima H; Kume S; Nakazawa J; Chin-Kanasaki M; Ugi S; Kawai H; Araki H; Uzu T; Maegawa H
    Clin J Am Soc Nephrol; 2015 Dec; 10(12):2152-8. PubMed ID: 26563378
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Spot urine sodium excretion as prognostic marker in acutely decompensated heart failure: the spironolactone effect.
    Ferreira JP; Girerd N; Medeiros PB; Santos M; Carvalho HC; Bettencourt P; Kénizou D; Butler J; Zannad F; Rossignol P
    Clin Res Cardiol; 2016 Jun; 105(6):489-507. PubMed ID: 26615605
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Association of Urinary Sodium Excretion With Blood Pressure and Cardiovascular Clinical Events in 17,033 Latin Americans.
    Lamelas PM; Mente A; Diaz R; Orlandini A; Avezum A; Oliveira G; Lanas F; Seron P; Lopez-Jaramillo P; Camacho-Lopez P; O Donnell MJ; Rangarajan S; Teo K; Yusuf S
    Am J Hypertens; 2016 Jul; 29(7):796-805. PubMed ID: 26683344
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Usefulness of heart rate at rest as a predictor of mortality, hospitalization for heart failure, myocardial infarction, and stroke in patients with stable coronary heart disease (Data from the Treating to New Targets [TNT] trial).
    Ho JE; Bittner V; Demicco DA; Breazna A; Deedwania PC; Waters DD
    Am J Cardiol; 2010 Apr; 105(7):905-11. PubMed ID: 20346304
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cardiovascular safety of linagliptin in type 2 diabetes: a comprehensive patient-level pooled analysis of prospectively adjudicated cardiovascular events.
    Rosenstock J; Marx N; Neubacher D; Seck T; Patel S; Woerle HJ; Johansen OE
    Cardiovasc Diabetol; 2015 May; 14():57. PubMed ID: 25990013
    [TBL] [Abstract][Full Text] [Related]  

  • 13. NSAID use and association with cardiovascular outcomes in outpatients with stable atherothrombotic disease.
    Kohli P; Steg PG; Cannon CP; Smith SC; Eagle KA; Ohman EM; Alberts MJ; Hoffman E; Guo J; Simon T; Sorbets E; Goto S; Bhatt DL;
    Am J Med; 2014 Jan; 127(1):53-60.e1. PubMed ID: 24280110
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Urinary sodium excretion, blood pressure, cardiovascular disease, and mortality: a community-level prospective epidemiological cohort study.
    Mente A; O'Donnell M; Rangarajan S; McQueen M; Dagenais G; Wielgosz A; Lear S; Ah STL; Wei L; Diaz R; Avezum A; Lopez-Jaramillo P; Lanas F; Mony P; Szuba A; Iqbal R; Yusuf R; Mohammadifard N; Khatib R; Yusoff K; Ismail N; Gulec S; Rosengren A; Yusufali A; Kruger L; Tsolekile LP; Chifamba J; Dans A; Alhabib KF; Yeates K; Teo K; Yusuf S
    Lancet; 2018 Aug; 392(10146):496-506. PubMed ID: 30129465
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Factors associated with heart failure hospitalization in patients with high sodium excretion: subanalysis of the ESPRIT, evaluation of sodium intake for the prediction of cardiovascular events in Japanese high-risk patients, cohort study.
    Sadanaga T; Hirota S; Mitamura H
    Heart Vessels; 2021 Jan; 36(1):85-91. PubMed ID: 32720095
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Association between 24h Urinary Sodium and Potassium Excretion and Estimated Glomerular Filtration Rate (eGFR) Decline or Death in Patients with Diabetes Mellitus and eGFR More than 30 ml/min/1.73m2.
    Nagata T; Sobajima H; Ohashi N; Hirakawa A; Katsuno T; Yasuda Y; Matsuo S; Tsuboi N; Maruyama S
    PLoS One; 2016; 11(5):e0152306. PubMed ID: 27136292
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Impact of candesartan on nonfatal myocardial infarction and cardiovascular death in patients with heart failure.
    Demers C; McMurray JJ; Swedberg K; Pfeffer MA; Granger CB; Olofsson B; McKelvie RS; Ostergren J; Michelson EL; Johansson PA; Wang D; Yusuf S;
    JAMA; 2005 Oct; 294(14):1794-8. PubMed ID: 16219883
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Thiazolidinedione use is not associated with worse cardiovascular outcomes: a study in 28,332 high risk patients with diabetes in routine clinical practice: brief title: thiazolidinedione use and mortality.
    Roussel R; Hadjadj S; Pasquet B; Wilson PW; Smith SC; Goto S; Tubach F; Marre M; Porath A; Krempf M; Bhatt DL; Steg PG
    Int J Cardiol; 2013 Aug; 167(4):1380-4. PubMed ID: 22560911
    [TBL] [Abstract][Full Text] [Related]  

  • 19. 24-Hour Urinary Sodium and Potassium Excretion and Cardiovascular Risk.
    Ma Y; He FJ; Sun Q; Yuan C; Kieneker LM; Curhan GC; MacGregor GA; Bakker SJL; Campbell NRC; Wang M; Rimm EB; Manson JE; Willett WC; Hofman A; Gansevoort RT; Cook NR; Hu FB
    N Engl J Med; 2022 Jan; 386(3):252-263. PubMed ID: 34767706
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Association of Fibroblast Growth Factor 23 With Recurrent Cardiovascular Events in Patients After an Acute Coronary Syndrome: A Secondary Analysis of a Randomized Clinical Trial.
    Bergmark BA; Udell JA; Morrow DA; Cannon CP; Steen DL; Jarolim P; Budaj A; Hamm C; Guo J; Im K; Kuder JF; Braunwald E; Sabatine MS; O'Donoghue ML
    JAMA Cardiol; 2018 Jun; 3(6):473-480. PubMed ID: 29710336
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 49.